Sequencing
Next-Generation Sequencing (NGS), Sanger Sequencing, and whole-genome sequencing services for clinical and research applications.
Sequencing Overview
BioMolds offers comprehensive sequencing services spanning Sanger Sequencing, Next-Generation Sequencing (NGS), and Whole Genome Sequencing (WGS). Our sequencing solutions support clinical diagnostics, oncology profiling, infectious disease identification, pharmacogenomics, and advanced genomic research across India.
Key Features
Sanger Sequencing
Gold-standard targeted sequencing for mutation confirmation, plasmid verification, and clinical diagnostics.
Next-Generation Sequencing (NGS)
High-throughput sequencing for whole-genome, whole-exome, targeted panels, RNA-Seq, and amplicon sequencing.
Whole Genome Sequencing (WGS)
Complete genome coverage for pathogen identification, rare disease diagnosis, and population genomics.
Oncology Sequencing Panels
Custom and pre-designed panels for somatic mutation profiling, tumor mutational burden, and MSI analysis.
Viral & Microbial Genotyping
HIV-1, HBV, SARS-CoV-2, HPV genotyping, 16S/18S rRNA amplicon sequencing for microbiome studies.
Drug Resistance Sequencing
CMV UL54/UL97, HSV TK/POL, HCV NS5A resistance panels for antiviral therapy guidance.
Detailed Description
Our sequencing facility is equipped to handle everything from basic plasmid sequencing to complex tumor profiling and whole-genome studies. We provide high-quality data with fast turnaround times and expert bioinformatics support to accelerate your clinical and research discoveries.
All sequencing runs are performed under strict QC protocols with comprehensive data reporting. We support downstream analysis including variant calling, annotation, pathway enrichment, and clinical interpretation for both research and diagnostic use.
All Services
Need Consultation?
Our clinical and research experts are ready to assist you with tailored solutions.
WhatsApp Nowbiomolediscsol@biomolds.com